Chen FM, Jin Y Periodontal tissue engineering and regeneration: current approaches and expanding opportunities. Tissue Eng Part B Rev. 2010 Apr;16(2):219-55. doi: 10.1089/ten.TEB.2009.0562. Review.
Park JC, Kim JM, Jung IH, Kim JC, Choi SH, Cho KS, Kim CS Isolation and characterization of human periodontal ligament (PDL) stem cells (PDLSCs) from the inflamed PDL tissue: in vitro and in vivo evaluations. J Clin Periodontol. 2011 Aug;38(8):721-31. doi: 10.1111/j.1600-051X.2011.01716.x. Epub 2011 Mar 30.
Simsek SB, Keles GC, Baris S, Cetinkaya BO Comparison of mesenchymal stem cells and autogenous cortical bone graft in the treatment of class II furcation defects in dogs. Clin Oral Investig. 2012 Feb;16(1):251-8. doi: 10.1007/s00784-010-0486-7. Epub 2010 Nov 18.
Yang Y, Rossi FM, Putnins EE Periodontal regeneration using engineered bone marrow mesenchymal stromal cells. Biomaterials. 2010 Nov;31(33):8574-82. doi: 10.1016/j.biomaterials.2010.06.026. Epub 2010 Sep 15.
Yang ZH, Jin F, Zhang XJ, Liu X, Zhang YF, Liu JQ, Duan YZ, Jin Y A novel possible strategy based on self-assembly approach to achieve complete periodontal regeneration. Artif Organs. 2010 Jul;34(7):603-9. doi: 10.1111/j.1525-1594.2009.00991.x. Epub 2010 Jun 10.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
